We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Development of New Prenatal Diagnostic Tests From Maternal Blood

This study has been terminated.
(Leaving of the person responsible for the data collection)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00314691
First Posted: April 14, 2006
Last Update Posted: July 28, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
University Hospital, Strasbourg, France
  Purpose
After extraction of the cell-free DNA circulating in maternal plasma, we aim at developing new techniques for fetal DNA enrichment to perform fetal gender determination, and indirect diagnosis of inherited diseases like Cystic Fibrosis, Huntington Disease, Myotonic Dystrophy, B-Thalassaemia...

Condition Intervention
Hereditary Diseases Genetic: Blood samples

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: Development of New Prenatal Diagnostic Tests From Maternal Blood

Further study details as provided by University Hospital, Strasbourg, France:

Primary Outcome Measures:
  • Feasibility of fetal gender and genotype determination out of maternal blood

Enrollment: 10
Study Start Date: April 2006
Estimated Study Completion Date: September 2006
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Mother and father-to-be both older than 18 years old
  • Mother and father-to-be affiliated to social security
  • Mother and father-to-be have good understanding of the protocol
  • Pregnancy of the mother-to-be attested

Exclusion Criteria:

  • Mother and father-to-be are younger than 18 years old
  • Mother and/or father-to be refusing to participate
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00314691


Locations
France
Sihcus-Cmco
Strasbourg, Schiltigheim, France, 67300
Sponsors and Collaborators
University Hospital, Strasbourg, France
Investigators
Principal Investigator: Romain FAVRE, MD SIHCUS-CMCO de Schiltigheim, Strasbourg, FRANCE
  More Information

ClinicalTrials.gov Identifier: NCT00314691     History of Changes
Other Study ID Numbers: 3612
First Submitted: April 12, 2006
First Posted: April 14, 2006
Last Update Posted: July 28, 2011
Last Verified: July 2007

Keywords provided by University Hospital, Strasbourg, France:
fetal DNA
prenatal diagnosis
maternal plasma
Diagnostic potential of cell-free fetal DNA circulating in maternal blood

Additional relevant MeSH terms:
Genetic Diseases, Inborn